Last updated on

Research Hotspot & Journal Scope - Metastatic

Pancreas - DOI: 10.1097/MPA.0000000000001294
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer

Vilma Pacheco-Barcia · Rebeca Mondéjar Solís · Talya France · Jamil Asselah · Olga Donnay · George Zogopoulos · Nathaniel Bouganim · Katie Guo · Jacobo Rogado · Elena Martin · Thierry Alcindor · Ramon Colomer ·

Pancreas - DOI: 10.1097/MPA.0000000000001234
The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma

Julien Péron · Joris Giai · Delphine Maucort-Boulch · Marc Buyse ·

Biology Medicine
Pancreas - DOI: 10.1097/MPA.0000000000001274
Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors: Comparison Between Primary and Metastatic Tumors

Rashmi T Samdani · Amanda R Wasylishen · Daniel M Halperin · Arvind Dasari · James C Yao · Asif Rashid · Jeannelyn S Estrella ·

Pancreas - DOI: 10.1097/MPA.0000000000001266
Intraoperative Peritoneal Washing Cytology on Survival in Pancreatic Ductal Adenocarcinoma With Resectable, Locally Advanced, and Metastatic Disease

Zi Yin · Tingting Ma · Sheng Chen ·


It has a poor prognosis because of a late diagnosis, high metastatic potential and resistance to conventional therapies.

Plasticité phénotypique et thérapies ciblées dans les cancers bronchiques non à petites cellules [10.1016/J.RMR.2019.03.004]

It also shows the potentially fatal phenomenon can be fully reversible when diagnosed and managed promptly even in patients with metastatic cancer and critical illness.

Fluorouracil-induced Takotsubo cardiomyopathy causing cardiogenic shock: a case report of clinical and acute cardiac magnetic resonance imaging features [10.1093/ehjcr/ytz146]

When tumor cells arrive in the bone microenvironment they home to the bone metastatic niche (comprised of the endosteal, hematopoietic stem cell and peri-vascular niches).

Tumor dormancy in the bone [10.1016/b978-0-12-801238-3.11239-5]

Delivery of personalized, effective therapy to patients with metastatic lung cancer with an identified driver mutation can be challenging and rewarding.

Nursing Considerations for Patients Treated with Targeted Therapies [10.1007/978-3-030-16550-5_9]

This S system accounts for the number of lymph node stations harboring metastatic lymph nodes—defined here as S0 (no metastatic nodes), S1 (1 station with metastatic nodes), S2 (2–3 stations with metastatic nodes), and S3 (C 4 stations with metastatic nodes)—while the traditional number-based system accounts for the overall number of metastatic nodes without regard for location.

Setting the Stage for Esophageal Cancer: Bulk versus Breadth [10.1245/s10434-019-07605-3]

Highly Related Keywords from Metastatic

Research Hotspot


Research Hotspot
Pancreas Related Journals

Popular Journals